Bayer is backing up its move into the cell therapy category led by subsidiary BlueRock Therapeutics with a $250 million investment in a new manufacturing facility in Berkeley, California.The newly-opened Cell Therapy Launch Facility will provide cell culture, viral transduction and automated filling of cell therapies, as well as process development, analytics, and clinical to […]
